Serum sialic acid, a reputed cardiovascular risk factor, is related to serum leptin concentrations in Fijians

Clinica Chimica Acta

Volumn 331, Issue 1-2, 2003, Pages 1-5

  Crook, M A ^a   Miell, J ^b   Ameerally, P ^a   Lumb, P ^a   Singh, N ^c   Russell Jones, D ^d   Goldsmith, L ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c Medical Center   (Fiji)

^d St Luke's Hospital Guildford   (United Kingdom)

Author keywords

Acute phase proteins; Insulin resistance; Leptin; Sialic acid

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; LEPTIN; SIALIC ACID; SOMATOMEDIN BINDING PROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; FIJI; GLUCOSE BLOOD LEVEL; HIP; HUMAN; HYPOTHESIS; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 12444270042     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00011-1     Document Type: Article

References (40)

1. Lindberg G., Eklund G., Gullberg B., Rastam L. Serum sialic acid concentration and cardiovascular mortality. Br. Med. J. 302:1991;143-146.
2. Lindberg G., Rastam L., Gullberg B., Eklund G.A. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow up. Int. J. Epidemiol. 21:1992;253-257.
3. Crook M., Haq M., Haq S., Tutt P. Serum sialic acid and acute phase proteins in patients with myocardial infarction. Angiology. 45:1994;709-715.
4. Haq M., Haq S., Tutt P., Crook M. Serum total sialic acid and lipid associated sialic acid in normal subjects and those having a myocardial infarction and their relation to acute phase proteins. Ann. Clin. Biochem. 30:1993;383-386.
5. Crook M., Tutt P., Pickup J.C. Serum sialic acid in non-insulin dependent diabetes mellitus and its relationship to blood pressure and retinopathy. Diabetes Care. 16:1993;57-60.
6. Crook M., Simpson H., Tutt P., Pickup J. Serum total sialic acid and acute phase proteins in type 1 diabetes mellitus. Clin. Chim. Acta. 219:1993;131-138.
7. Crook M., Earle K., Morocutti A., Yip J., Viberti G., Pickup J.C. Serum sialic acid, a risk factor for cardiovascular disease is increased in insulin-dependent diabetic patients with microalbuminuria and clinical proteinuria. Diabetes Care. 17:1994;305-310.
8. Chen J., Gall M.A., Yokohama H., Jensen J.S., Deckert M., Parving H.H. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care. 19:1996;130-134.
9. Taniuchi K., Chifu K., Hayashi N. A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. Kobe J. Med. Sci. 27:1981;91-102.
10. Crook M.A. Serum sialic acid and its relevance to diabetes mellitus. Endocrinol. Metab. 3:1996;207-213.
11. Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system. Diabetologia. 40:1997;1286-1292.
12. Bhabra S., Lumb P., Crook M. Serum sialic acid and its relationship to serum IL-6 in type 2 diabetes mellitus. Med. Biochem. 1:1999;243-246.
13. Pickup J.C., Crook M. Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia. 41:1998;1241-1248.
14. Crook M., Andrews V., Lumb P., Swaminathan R. Serum sialic acid, a reputed cardiovascular risk factor, and its relationship to serum lipids, fasting plasma insulin and glucose and blood pressure in healthy individuals. Clin. Sci. 95:1998;53-57.
15. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
16. Halaas J., Gajiwala K., Maffei M., Cohen S., Chait B. Weight reducing effects of the plasma protein encoded by the ob gene. Science. 269:1995;543-546.
17. Tartaglia L., Demski M., Weng X., Dang N., Culpepper J., Devos R.et al. Identification and expression cloning of a leptin receptor OB-R. Cell. 83:1995;1263-1271.
18. Lee G.H., Procena R., Montez J.M., Carroll K.M., Darvishzadeh J.G., Lee J.I.et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:1996;632-635.
19. Powell D.R., Suwanichkul A., Cubbage M.L.et al. Insulin inhibits transcription of the human gene for IGFBP-1. J. Biol. Chem. 266:1991;18868-18876.
20. Crook M. The determination of serum or plasma sialic acid. Clin. Biochem. 26:1993;31-37.
21. Pickup J.C., Chusney G.D., Mattock M.B. The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute phase) reaction. Clin. Endocrinol. 52:2000;107-112.
22. Samstein B., Hoimes M.L., Fan J., Frost R.A., Gelato M.C., Lang C.H. IL-6 stimulation of insulin like growth factor binding protein 1 production. Biochem. Biophys. Res. Commun. 228:1996;611-615.
23. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S.et al. Subcutaneous adipose tissue releases IL-6 but not TNF-alpha in vivo. J. Clin. Endocrinol. Metab. 82:1997;4196-4200.
24. Yudkin J.S., Stehouwer C.D., Emeis J.J., Coppack S.W. CRP in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19:1999;972-978.
25. Mohamed-Ali V., Pinkney J.H., Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Rel. Metabol. Disord. 22:1998;1145-1158.
26. Mantzoros C.S. The role of leptin in human obesity and disease. Ann. Intern. Med. 130:1999;671-680.
27. Janik J.E., Curti B.D., Considine R.V., Rager H.C., Powers G.C., Alvord W.G.et al. Interleukin 1 alpha increases serum leptin concentrations in humans. J. Clin. Endocrinol. Metab. 82:1997;3084-3086.
28. Luheshi G.N., Gardner J.D., Rushforth D.A., Loudon A.S., Rothwell N.J. Leptin actions on food intake and body temperature are mediated by IL-1. Proc. Natl. Acad. Sci. 96:1999;7047-7052.
29. Sarraf P., Frederich R.C., Turner E.M., Ma G., Jaskowiak N.T., Rivet D.J.et al. Multiple cytokines and acute inflammation raise mouse leptin levels; potential role in inflammatory anorexia. J. Exp. Med. 185:1997;171-175.
30. Grunfeld C., Zhao C., Fuller J., Pollack A., Moser A., Friedman J.et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97:1996;2152-2157.
31. Kirchgessner T.G., Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Tumour necrosis factor alpha contributes to obesity related hyperleptinaemia by regulating leptin release from adipocytes. J. Clin. Invest. 100:1997;2777-2782.
32. Plata-Salaman C.R. Cytokine induced anorexia: behavioural, cellular and molecular mechanisms. Ann. N.Y. Acad. Sci. 856:1998;160-170.
33. Agnello D., Meazza C., Rowan C.G., Villa P., Ghezzi P., Senaldi G. Leptin causes body weight loss in the absence of in vivo activities typical of cytokines of the IL-6 family. Am. J. Physiol. 275:1998;913-919.
34. Stratton R.J., Dewit O., Crowe E., Jennings G., Villar R.N., Elia M. Plasma leptin, energy intake and hunger following total hip replacement surgery. Clin. Sci. 93:1997;113-117.
35. Arnalich F., L'Pez J., Codoceo R., Jimnez M., Madero R., Montiel C. Relationship of plasma leptin to plasma cytokines and human survival in sepsis and septic shock. J. Infect. Dis. 180:1999;908-911.
36. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L.et al. Leptin regulates proinflammatory immune responses. FASEB J. 12:1998;57-65.
37. Bjoraek C., Elmquist J., Frantz J., Shoelson S., Flier J. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell. 1:1998;619-625.
38. Schmidt M.I., Duncan B.B., Sharrett A.R., Lindberg G., Savage P.J.et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet. 353:1999;1649-1652.
39. Lindsay R.S., Krakoff J., Hanson R.L., Bennett P.H., Knowler W.C. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes. 50:2001;1598-1603.
40. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin-6 and risk of developing type 2 diabetes mellitus. J. Am. Med. Assoc. 286:2001;327-334.